[Trastuzumab Deruxtecan引起的和吐的现状和问题]
Ai Soma1, Fumie Fujisawa, Ayako Higuchi
1Dept. of Breast Surgery, Osaka International Cancer Institute.
特拉斯图祖马布德鲁克斯泰干 (T-DXd) 在晚期乳腺癌患者中经常引起延迟吐和吐. 对于50岁以下的患者或对中度 emetogenic 化疗 (MEC) 疗程反应不足的患者,请考虑高度 emetogenic 化疗 (HEC) 抗emetic 方案.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
13:59High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
Published on: August 18, 2023
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Prevention of Further Absorption of Poison
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
